Biotech, in particular companies that are pre-commercial with a longer-duration risk profile, could be great investments as Operation Epic Fury rolls on, according to a Truist Securities analysis.

Agreement Set to Expand BUZZ BOMB™ Distribution Across Natural, Specialty, and Mass Merchandiser Channels ESTERO, FL / ...

Quantum BioPharma Ltd. has announced the retention of Enterprise Canada Inc. and Empire Market Ventures, LLC to enhance its public relations and investor awareness programs in key markets. This ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

BEIJING, Sept. 22, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, ...

ESTERO, FL / ACCESS Newswire / March 17, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), wholly owned ...

Pharmaceutical organisations rarely struggle to write strategy. They struggle to protect it. Global brand teams define ambition precisely. Segmentation models are refined. Launch plans are ...

Fintel reports that on March 9, 2026, Citizens initiated coverage of Immix Biopharma (NasdaqCM:IMMX) with a Market Outperform ...

Good morning, Hubsters! Rafael Canton here with the US edition of the Wire from the New York newsroom. After the merger, Permira and Odyssey expect Valeris to be the largest independent patient access ...

LakeShore Biopharma Co., Ltd. has announced that the Shenyang Municipal Public Security Bureau is investigating former chairman Yi Zhang for misappropriating corporate assets and mismanagement, ...

First of its kind report offers insight from over 110 biopharma executives into the benefits of royalties, current market dynamics and outlook for royalty market expansion Royalties have become ...